Journals / Atatürk Üniversitesi Veteriner Bilimleri Dergisi / 2018 / Cilt: 13 - Sayı: 3

Behaviours of Drugs in the Milk - A Review

İlaçların Sütteki Davranışları - Derleme

Pages
364–372
Publication Date
2022-10-11
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

If thetransition properties of the compounds of concern are known or able to be modelized in kinetic applications, it can be usefulfor preventing milk from drug residues.The success of mastitis treatment depends on the proper use of drugs and knowingof the behaviour of drugs in the milk.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Milk is a food containing many biologically active substances that have an important place in the nourishment ofnewborns and adults.
📊
Key Findings & Data:The transition of the drugs used in the treatment, as well as the environmental pollutants to milk causea potential risk for consumer health as well as economical losses due to exceed of the legal limits of these compounds set byauthorities.
💡
Conclusion & Impact:If thetransition properties of the compounds of concern are known or able to be modelized in kinetic applications, it can be usefulfor preventing milk from drug residues.The success of mastitis treatment depends on the proper use of drugs and knowingof the behaviour of drugs in the milk.
🔬Design:Modeling & Simulation
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Milk is a food containing many biologically active substances that have an important place in the nourishment ofnewborns and adults. The transition of the drugs used in the treatment, as well as the environmental pollutants to milk causea potential risk for consumer health as well as economical losses due to exceed of the legal limits of these compounds set byauthorities. The transition of these chemicals to milk is complex; while active transport and passive diffusion play were foundto have an important role. The transition abilities of the drugs into milk are defined by milk/plasma ratio. The M/P ratios ofthe drugs are affected by the composition of the milk and the physicochemical properties of the drug. The concentration ofthe drugs in the milk depends on the factors of the drug (protein binding, ionization, molecular weight, lipophilicity, drugdrug and drug-nutrient interactions) and organism (race, species, lactation period, parity, disease and nutrition). If thetransition properties of the compounds of concern are known or able to be modelized in kinetic applications, it can be usefulfor preventing milk from drug residues.The success of mastitis treatment depends on the proper use of drugs and knowingof the behaviour of drugs in the milk.

Özet

Süt, yeni doğanlar ve yetişkinlerin beslenmesinde önemli yeri olan birçok biyolojik aktif madde içeren bir besindir. İnsan ve hayvanların tedavisinde kullanılan ilaçların ve çevresel kirleticilerin süte geçme yeteneği, sütü sağlık ve ekonomik açıdan sorunlu hale getirmektedir. Kaliteli ve güvenli gıda üretimine yönelik yasal ve bilimsel uygulamalar bu sorunları önlemeyi amaçlamaktadır. Aktif transport ve pasif difüzyon, ilaçların süte geçişinde önemli rol oynamakla birlikte diğer mekanizmaların da etkin olduğu bilinmektedir. İlaçların süte geçişlerisüt/plazma oranı ile belirlenir. Süt/plazma oranı sütün bileşiminden ve ilacın fizikokimyasal özelliklerinden etkilenir. Sütteki ilaç konsantrasyonu, ilaca (proteine bağlama, iyonizasyon, molekül ağırlığı, lipofiliklik, ilaç-ilaç ve ilaç-besin etkileşimi) ve canlıya (ırk, tür, laktasyon periyodu, doğum sayısı, hastalık ve beslenme) bağlı olarak değişiklik gösterir. Söz konusu bileşiklerin geçiş özelliklerinin bilinmesi veya kinetik uygulamalarla modellenebilmesi sütte ilaç kalıntılarının önlenmesinde faydalı olabilir. Mastitis tedavisinin başarısı, ilaçların doğru kullanılması ve ilaçların sütteki davranışlarının bilinmesine bağlıdır.

🔖

Cite This Article

TRAŞ, B., ÖZDEMİR, Z. (2022). Behaviours of Drugs in the Milk - A Review. Atatürk Üniversitesi Veteriner Bilimleri Dergisi, Cilt: 13 - Sayı: 3, 364–372. https://ajindex.com/articles/448530

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (11)

  1. Cheah Y., Kuhn RJ., 1995. Active transport of cimetidine into human milk. Clin Pharmacol Ther, 58, 548-555
  2. Gerk PM., Kuhn RJ., Desai NS., McNamara PJ., 2001. Active transport of nitrofurantoin into human milk. Pharmacotherapy, 21, 669-675
  3. Schadewinkel‐Scherkl AM., Rasmussen F., Merck CC., Nielsen P., Frey HH., 1993. Active Transport of Benzylpenicillin Across the Blood‐Milk Barrier. Pharmacol Toxicol, 73, 14-19
  4. Gerk PM., Hanson L., Neville MC., McNamara PJ., 2002. Sodium dependence of nitrofurantoin active transport across mammary epithelia and effects of dipyridamole, nucleosides, and nucleobases. Pharmacol Res, 19, 299-305
  5. Ito S., Alcorn J., 2003. Xenobiotic transporter expression and function in the human mammary gland. Adv Drug Deliv Rev, 55, 653-665
  6. Jonker JW., Merino G., Musters S., van Herwaarden AE., Bolscher E., Wagenaar E., Mesman E., Dale TC., Schinkel AF., 2005. The breast cancer resistance protein BCRP (ABCG2) concentrates drugs and carcinogenic xenotoxins into milk. Nat Med, 11,127-129
  7. Pulido MM., Molina AJ., Merino G., Mendoza G., Prieto JG., Alvarez AI., 2006. Interaction of enrofloxacin with breast cancer resistance protein (BCRP/ABCG2): influence of flavonoids and role in milk secretion in sheep. J Vet Pharmacol Ther, 29, 279-287
  8. Otero JA., Real R., de la Fuente A., Prieto JG., Marques M., Alvarez AI., Merino G., 2013. The bovine ATP-binding cassette transporter ABCG2 Tyr581Ser single-nucleotide polymorphism increases milk secretion of the fluoroquinolone danofloxacin. Drug Metab Dispos, 41, 546-549
  9. Otero J., Miguel V., Gonzalez-Lobato L., GarciaVillalba R., Espin J., Prieto JG., Merino G., Alvarez AI., 2016. Effect of bovine ABCG2 polymorphism Y581S SNP on secretion into milk of enterolactone, riboflavin and uric acid. Animal, 10, 238-247
  10. Weikard R., Widmann P., Buitkamp J., Emmerling R., Kuehn C., 2012. Revisiting the quantitative trait loci for milk production traits on BTA6. Anim Genet, 43, 318-323
  11. Barrera B., Gonzalez-Lobato L., Otero JA., Real R., Prieto JG., Alvarez AI., Merino G., 2013. Effects of triclabendazole on secretion of danofloxacin and moxidectin into the milk of sheep: Role of triclabendazole metabolites as inhibitors of the ruminant ABCG2 transporter. Vet J, 198, 429-436. 12.Otero J., Garcia-Mateos D., de la Fuente A., Prieto J., Alvarez A., Merino G., 2016. Effect of bovine ABCG2 Y581S polymorphism on concentrations in milk of enrofloxacin and its active metabolite ciproflo